Low testosterone (hypogonadism) is a condition where your body doesn’t produce enough of the hormone. It has several possible ...

Sex hormones and related substances have been used in the treatment of depressions for a number of years. Although the use of estrogenic substances of various types has yielded disappointing ...

New research has found that an existing ADHD medication greatly reduced the number of days people with a methamphetamine dependence used the drug. With no current drug treatment to assist people ...

Low testosterone or testosterone deficiency, also known as hypogonadism, is a condition in which patients develop symptoms.

Testosterone is the primary androgen — or male hormone — in your body. Low testosterone affects up to 39 percent of adult men in the US over the age of 45, and becomes increasingly prevalent ...

The Food and Drug Administration on Friday approved Eli Lilly’s weight-loss drug Zepbound to treat sleep apnea, a common but potentially serious sleep-related breathing disorder, marking it the ...

The U.S. Food and Drug Administration has approved the first generic version of Victoza (liraglutide injection), significantly improving access to diabetes treatment. The glucagon-like peptide-1 ...

Javascript must be enabled to use this site. Please enable Javascript in your browser and try again. Apply now for the AARP Purpose Prize awards, which recognize ...

The US FDA has approved the anti-diabetic drug Zepbound (Tirzepatide) for managing obstructive sleep apnea (OSA) in obese adults. Eli Lilly plans to launch the drug in India by 2025, pending ...

The FDA also recommends that prescribed users reduce their caloric intake and increase their exercise Charna Flam is a writer-reporter at PEOPLE. She has been working at PEOPLE since 2023.

The first medication for obstructive sleep apnea has been approved by the U.S. Food and Drug Administration (FDA). On Dec. 20, the FDA announced that the agency has approved Eli Lilly's Zepbound ...